Weidmann C E, Wallace D J, Peter J B, Knight P J, Bear M B, Klinenberg J R
Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine 90048.
J Rheumatol. 1988 Jan;15(1):74-9.
We evaluated the clinical relevance of 6 antiphospholipid antibodies including cardiolipin and their IgG, IgM and IgA isotypes in 92 patients with systemic lupus erythematosus (SLE). Antiphospholipid antibodies generally had significant associations with thrombocytopenia and a history of false-positive syphilis serologies. In 4 of 6 antiphospholipid antibodies, an inverse association with renal disease was observed. Antiphospholipid antibodies may moderate or protect against renal disease, or this may reflect the high doses of corticosteroids and cytotoxic drugs received by this group. Further studies are needed to determine how many antibody families cause these activities and to elucidate whether certain SLE subgroups possess differing specificities for each of the phospholipids.
我们评估了包括心磷脂在内的6种抗磷脂抗体及其IgG、IgM和IgA亚型在92例系统性红斑狼疮(SLE)患者中的临床相关性。抗磷脂抗体通常与血小板减少症以及梅毒血清学假阳性病史显著相关。在6种抗磷脂抗体中的4种中,观察到与肾脏疾病呈负相关。抗磷脂抗体可能减轻或预防肾脏疾病,或者这可能反映了该组患者接受的高剂量皮质类固醇和细胞毒性药物。需要进一步研究以确定有多少抗体家族导致这些活动,并阐明某些SLE亚组对每种磷脂是否具有不同的特异性。